WeGuide alternatives: compare 31 clinical research platforms (2026)
WeGuide is the patient-first clinical research platform that replaces three to five stitched tools with one, configured alongside your team in weeks rather than months. Whether you're outgrowing REDCap, frustrated with OpenClinica's setup, or evaluating enterprise platforms like Medidata, Veeva, Oracle, IQVIA, or Clario, this hub walks through how WeGuide compares across every dimension that matters.
No pressure, no hard sell. A 30-minute walkthrough with a research colleague who's built platforms like yours. Cancel anytime, no commitment.
.webp)
31
side by side platform comparisons
Used by leading research and medical institutes.








%201.avif)










Why research teams compare clinical trial platforms
Platform choice has a compounding effect on a study. The right fit reduces implementation weeks, lifts participant adherence, and removes the procurement friction of stitching five tools together.
Most evaluations land on one of three questions:
"We're outgrowing REDCap or OpenClinica." You need eCOA, eConsent, wearables, and a participant mobile app that open-source tools weren't built for.
"We're priced out of Medidata, Veeva, Oracle, or Medable." Enterprise platforms bill at six and seven figures with 3-to-6-month implementations. Mid-market research budgets don't absorb that.
"We need a technology platform, not a CRO services contract." IQVIA, Science 37, Thread, and ObvioHealth bundle services with the platform. For teams that own study operations or already work with a CRO, a pure technology platform is a cleaner fit.
WeGuide sits in a specific place in this market: a patient-first clinical research platform with whitelabel mobile apps, native wearable integration, and a library of validated instruments, priced for mid-market sponsors, academic research, CROs, and health organisations. It isn't a replacement for every platform below, and we'll say so wherever it's true.
%20(1).webp)
Why WeGuide wins when it's the right fit
When the use case matches, here's what changes for research teams who move to WeGuide.
.webp)
Engagement that keeps participants in the study
.webp)
Configured in weeks, not months
.webp)
One platform, not five stitched tools
.webp)
Compliance built in from day one
All comparisons
Find the comparison you need
Filter by the kind of platform you are weighing up. Each page sets out where WeGuide fits, where the other platform is stronger, and how a move works.
WeGuide across every research use case
Case studies: research at scale
BRACE Trial (Murdoch Children's Research Institute)
An international randomised trial testing whether the BCG vaccine could protect healthcare workers during COVID-19, run across several countries with thousands of participants. It was a hybrid design: vaccination and blood collection happened in person, and WeGuide supported the participant facing side of the study between those site contacts.
GenV (Generation Victoria)
A whole of state longitudinal birth cohort covering roughly 124,000 Victorians: about 50,000 children and 74,000 parents. Longitudinal data collection, multi-year participant relationships, and a family-branded whitelabel app. Registry work that most DCT-focused competitors don't offer natively.
FSHD Global Registry
A rare disease patient registry for facioscapulohumeral muscular dystrophy, running globally with longitudinal participant engagement. Another registry use case outside DCT-only competitors' scope.
Frequently asked questions
Straight answers on how WeGuide compares across the major clinical trial platforms.
Contact usHow does WeGuide compare to REDCap?
REDCap is free and excellent for academic survey research with 7,000+ institutions. WeGuide adds a whitelabel participant mobile app, native wearable integration (Garmin, Apple Health, Health Connect and Fitbit Air), built-in eConsent with version control, TGA registered Class I medical device software, and multilingual translation management. For studies that need engagement, eCOA, eConsent, or wearables, WeGuide extends beyond REDCap's academic survey scope. For pure data collection on a zero-dollar budget with institutional IT support, REDCap is still a strong choice and we'll say so. See the full REDCap comparison →
How does WeGuide compare to OpenClinica?
OpenClinica is an EDC first open source platform with strong eCRF design and edit check capability. WeGuide is patient-first, with EDC available via Integration Engine rather than natively. The two are complementary for studies that combine deep EDC requirements with participant engagement. For pure site-based EDC with eCRFs, OpenClinica is hard to beat. For ePRO, eConsent, wearables, patient registries, or employee wellbeing, WeGuide covers the ground OpenClinica doesn't.
Which platforms support native wearable data collection?
WeGuide integrates natively with Garmin, Apple Health, Health Connect and Fitbit Air, and collects raw accelerometer and gyroscope data at 25 Hz from supported Garmin models. Most competitors (Medable, Medidata, Veeva, Oracle, Thread, ObvioHealth) support wearables via partner integrations or connected device layers. Clario provisions validated devices rather than supporting BYOD wearables. WeGuide supports both participants' own devices and devices the sponsor provides.
Is WeGuide TGA registered, and does it support FDA 21 CFR Part 11 requirements?
Yes. WeGuide is TGA registered Class I medical device software (ARTG 355337), is ISO 27001:2022 certified, and supports FDA 21 CFR Part 11, HIPAA and GDPR requirements. Australian data residency is a first-class offering for APAC sponsors and academic research.
How quickly can I deploy a study with WeGuide?
Configuration alongside your team typically takes two to four weeks after the discovery call, followed by launch and a named delivery contact. Enterprise platforms (Medidata, Veeva, Oracle, Medable) typically measure implementation in three to six months with a services engagement. The no code Form Builder lets research coordinators configure studies directly rather than handing specs to a services team.
Can WeGuide handle multilingual studies?
Yes. INHERIT used WeGuide's dynamic translation management and culturally adapted content for multilingual community research during COVID-19. Multilingual translation management is built into the platform rather than requiring per language survey configuration.
Does WeGuide integrate with existing EDCs?
Yes. Integration Engine connects to Medidata Rave, Veeva Vault, REDCap, Viedoc, Clinion, Oracle InForm, and custom EDCs. For sponsors who already have an EDC preference or want flexibility, WeGuide runs alongside rather than replacing. Many teams pair WeGuide (participant-facing) with their existing EDC (data management).
How does pricing compare across clinical trial platforms?
Enterprise platforms (Medidata, Veeva, Oracle, Medable, Clario, IQVIA) bill at six and seven figures with multi year contracts, often bundled with services. Services led platforms (Science 37, ObvioHealth, Thread) bundle virtual CRO or consulting scope into the quote. WeGuide is technology only project-based pricing with every module included in the core licence, priced accessibly for mid market sponsors, academic research, and CROs. REDCap and OpenClinica community edition are free but require institutional IT to run.
See how WeGuide fits your study.
A 30 minute walkthrough with a research colleague, focused on your protocol, your participants and the tools you already run.

































%201.avif)





